JP2003519176A5 - - Google Patents

Download PDF

Info

Publication number
JP2003519176A5
JP2003519176A5 JP2001549643A JP2001549643A JP2003519176A5 JP 2003519176 A5 JP2003519176 A5 JP 2003519176A5 JP 2001549643 A JP2001549643 A JP 2001549643A JP 2001549643 A JP2001549643 A JP 2001549643A JP 2003519176 A5 JP2003519176 A5 JP 2003519176A5
Authority
JP
Japan
Prior art keywords
embedded image
nitrate
group
image embedded
scn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001549643A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003519176A (ja
Filing date
Publication date
Priority claimed from US09/473,713 external-priority patent/US7115661B1/en
Application filed filed Critical
Publication of JP2003519176A publication Critical patent/JP2003519176A/ja
Publication of JP2003519176A5 publication Critical patent/JP2003519176A5/ja
Pending legal-status Critical Current

Links

JP2001549643A 1999-12-29 2000-12-27 痛みを緩和する方法および組成物 Pending JP2003519176A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/473,713 US7115661B1 (en) 1999-12-29 1999-12-29 Methods and compositions for mitigating pain
US09/473,713 1999-12-29
PCT/CA2000/001523 WO2001049275A2 (en) 1999-12-29 2000-12-27 Methods and compositions for mitigating pain using nitrate esters

Publications (2)

Publication Number Publication Date
JP2003519176A JP2003519176A (ja) 2003-06-17
JP2003519176A5 true JP2003519176A5 (enExample) 2008-02-21

Family

ID=23880683

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001549643A Pending JP2003519176A (ja) 1999-12-29 2000-12-27 痛みを緩和する方法および組成物

Country Status (12)

Country Link
US (2) US7115661B1 (enExample)
EP (2) EP1518553A2 (enExample)
JP (1) JP2003519176A (enExample)
AT (1) ATE283695T1 (enExample)
AU (1) AU782489C (enExample)
CA (1) CA2394184A1 (enExample)
DE (1) DE60016460T2 (enExample)
DK (1) DK1246625T3 (enExample)
ES (1) ES2233489T3 (enExample)
IL (1) IL150487A0 (enExample)
PT (1) PT1246625E (enExample)
WO (1) WO2001049275A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137191A1 (en) * 1996-06-04 2005-06-23 Thatcher Gregory R. Nitrate esters and their use for mitigating cellular damage
US20040077702A1 (en) * 2001-09-14 2004-04-22 Wen-Mei Fu Treatment of nuerodegenerative diseases
US7049334B2 (en) * 2001-09-14 2006-05-23 Carlsbad Technology, Inc. Enhancement of learning and memory and treatment of amnesia
JP2005539089A (ja) * 2002-07-03 2005-12-22 ニトロメッド インコーポレーティッド ニトロソ化非ステロイド性抗炎症化合物、組成物および使用方法
CA2493156A1 (en) 2002-07-29 2004-02-05 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
JP2005089457A (ja) * 2003-09-03 2005-04-07 Yung Shin Pharmaceutical Industry Co Ltd 骨成長を促進するまたは骨吸収を阻害するための薬剤組成物
US7498445B2 (en) 2004-05-05 2009-03-03 Renopharm Ltd. Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof
US7968575B2 (en) 2004-05-05 2011-06-28 Renopharm Ltd. Nitric oxide donors and uses thereof
US7189750B2 (en) * 2004-05-05 2007-03-13 Renopharm Ltd. Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof
EP1753734A1 (en) * 2004-05-05 2007-02-21 Renopharm Ltd. Nitric oxide donors and uses thereof
US8134010B2 (en) 2004-05-05 2012-03-13 Renopharm Ltd. Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
AU2005281359A1 (en) 2004-08-26 2006-03-16 Apparao Satyam Prodrugs and codrugs containing novel bio-cleavable disulfide linkers
AU2005284573A1 (en) * 2004-09-17 2006-03-23 Queen's University At Kingston Nitrate esters and their use for mitigating cellular damage
WO2009044902A1 (ja) 2007-10-05 2009-04-09 Kyushu Institute Of Technology 誘電泳動装置および方法
US20100035929A1 (en) * 2008-06-09 2010-02-11 Lindsley Craig W Unnatural dispyrin analogues, preparation and uses thereof
WO2010011650A1 (en) * 2008-07-21 2010-01-28 Imi International Medical Innovations (D/B/A Procris Pharmaceuticals) Stable water-based topical pharmaceutical creams and methods of making and using same
US7807716B2 (en) * 2008-09-24 2010-10-05 Oral Delivery Technology Ltd. Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
US8957086B2 (en) * 2010-05-05 2015-02-17 The Board Of Trustees Of The University Of Illinois Compounds and methods of treating brain disorders
WO2014013338A2 (en) * 2012-07-16 2014-01-23 Sgc Pharma, Inc. Compounds for the treatment of alzheimer's disease
WO2014039042A1 (en) 2012-09-06 2014-03-13 Northeastern University Novel cannabinergic compounds and uses thereof
US11964956B2 (en) 2012-09-06 2024-04-23 Northeastern University Cannabinergic compounds and uses thereof
US9580400B2 (en) * 2013-02-26 2017-02-28 Northeastern University Cannabinergic nitrate esters and related analogs
WO2017041701A1 (zh) 2015-09-07 2017-03-16 浙江华海药业股份有限公司 可释放一氧化氮的前药分子

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1376892A (en) 1970-11-12 1974-12-11 Glaxo Lab Ltd 2beta-substituted-3alpha-hydroxysteroids and their esters
DE3443998A1 (de) 1984-12-01 1986-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
JPS62205052A (ja) 1986-03-05 1987-09-09 Terumo Corp 硝酸エステル誘導体およびこれを含有する血管拡張剤
US5428061A (en) 1988-09-15 1995-06-27 Schwarz Pharma Ag Organic nitrates and method for their preparation
NL8802276A (nl) 1988-09-15 1990-04-02 Cedona Pharm Bv Geneesmiddel met relaxerende werking, dat als aktieve stof een nitraatester bevat.
US5284872A (en) 1989-09-12 1994-02-08 Schwarz Pharma Ag Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof
IT1256450B (it) 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
DE4321306A1 (de) 1993-06-26 1995-01-05 Sanol Arznei Schwarz Gmbh Disulfide
JP3775796B2 (ja) 1993-10-06 2006-05-17 ニコックス エス エイ 抗炎症活性及び/又は鎮痛活性を有する硝酸エステル類及びそれらの製造方法
JP3276762B2 (ja) 1993-12-28 2002-04-22 日本臓器製薬株式会社 イソキノリン誘導体を含有する医薬組成物
RU2145595C1 (ru) 1994-05-10 2000-02-20 Никокс С.А. Нитроксисоединения и фармацевтическая композиция на их основе, имеющие противовоспалительную, анальгетическую и антитромбоцитарную активности
PT719145E (pt) 1994-05-27 2001-01-31 Cellegy Pharma Inc Composicao dadora de oxido nitrico para tratamento de desordens anais
TW458776B (en) * 1995-08-15 2001-10-11 Chugai Pharmaceutical Co Ltd Pharmaceutical composition for the treatment of anxiety neurosis
IT1276071B1 (it) 1995-10-31 1997-10-24 Nicox Ltd Compositi ad attivita' anti-infiammatoria
US5807847A (en) * 1996-06-04 1998-09-15 Queen's University At Kingston Nitrate esters
US6310052B1 (en) 1996-06-04 2001-10-30 Queen's University At Kingston Nitrate esters and their use for neurological conditions
FR2757159B1 (fr) 1996-12-12 1999-12-17 Hoechst Marion Roussel Inc Nouveaux derives nitres analgesiques, anti-inflammatoires et anti-thrombotiques, leur procede de preparation, leur application comme medicaments
IL120531A (en) 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them

Similar Documents

Publication Publication Date Title
RU2221798C2 (ru) Имидазонафтиридины, фармацевтическая композиция на их основе, способ стимуляции биосинтеза цитокина и промежуточные вещества
WO2002032912A3 (en) Phosphinoamidite carboxylates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge
JP2002539152A5 (enExample)
DE60216490D1 (en) Mehrfunktionelle thioxanthon-photoinitiatoren
CA2012686A1 (en) Treatment and compounds
JP2004506645A5 (enExample)
DE60222283D1 (de) Multifunktionelle photoinitiatoren
AU1099302A (en) Medicinal compositions for concominant use as anticancer atent
KR890701562A (ko) 면역조절 아자스 피란류
CA2192555A1 (en) 2-acylaminopropanol compound and medicinal composition
EP1826196A3 (en) Vinyl ether compounds
IL148968A0 (en) Neutral-cationic lipid for nucleic acid and drug delivery
KR940005534A (ko) 아릴글리신아미드 유도체, 이의 제조방법 및 활성성분으로서 이를 함유하는 배뇨 장해 치료제
WO2005046672A3 (fr) Utilisation d’inhibiteurs de glucosidase pour une therapie de la mucoviscidose
RU2003134629A (ru) Соединения цефема
CA2053820A1 (en) Method of Inhibiting Metabolism of Cholesterol
CA2459887A1 (en) Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
CA2217026A1 (en) New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients
WO2001083457A3 (en) Benzimidazole-2-carbamates and their use in cancer treatment
RU2007132737A (ru) Новый пиримидиновый нуклеозид или его соль
CA2492196A1 (en) Sulfotransferase inhibitors
PL345066A1 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
NZ514990A (en) Releasable linkage and compositions containing same
KR970706825A (ko) 헬리코박터의 감염에 기인하는 질환의 치료제(remedy for diseases caused by infection with helicobacter)